Repare Therapeutics

About:

Repare Therapeutics is a developer of oncology drugs designed to target specific vulnerabilities of tumor cells.

Website: http://www.reparerx.com/

Twitter/X: RepareRx

Top Investors: Fonds de solidarité FTQ, OrbiMed, Amplitude Venture Capital, Versant Ventures, Redmile Group

Description:

Repare Therapeutics is a developer of oncology drugs designed to target specific vulnerabilities of tumor cells. The company's drugs combine a proprietary high throughput gene-editing and target discovery method with high-resolution protein crystallography, computational biology and clinical informatics, enabling patients to improve cancer treatment both with single therapy and in combination with existing drugs and treatments.

Total Funding Amount:

$252M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Saint Laurent, Quebec, Canada

Founded Date:

2016-01-01

Contact Email:

info(AT)reparerx.com

Founders:

Agnel Sfeir, Daniel Durocher, Frank Sicheri

Number of Employees:

101-250

Last Funding Date:

2021-10-27

IPO Status:

Public

Industries:

© 2025 bioDAO.ai